Skip to content

Serankottai nei(Internal) and vanga vennai(External) in the treatment of Skin disease.

A Pilot Study to Evaluate the Efficacy of Siddha Drugs Serankottai nei(Internal) and Vanga vennai(External) in the treatment of Padarthamarai (Dermatophytosis) - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/060088
Enrollment
25
Registered
2023-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Serankottai nei(Internal) Vanga vennai (External): 5ml twice a day with milk for 48 days Control Intervention1: NA: NA

Sponsors

Dr K Saravanasingh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Typical distribution of the lesions with well defined raised margin on the face, axilla, body, inguinal regions. Marked itching,hyperpigmentation and dryness. Willing to give specimen of blood for the investigation whenever required. Willing to take photograph Willing to participate in trial and signing consent by fulfilling the condition of Proforma.

Exclusion criteria

Exclusion criteria: History of Insulin Dependent Diabetes Mellitus, Pregnancy and lactation Evidences of secondary infection in the lesions Patient with age less than 18 years and greater than 60 years. Patient not willing to take photography

Design outcomes

Primary

MeasureTime frame
To assess the improvement in the condition of padarthamarai by using skindex 29 questionnarie.Timepoint: 48 days

Secondary

MeasureTime frame
To assess the improvement by comparing baseline and end of the treatment photographs.Timepoint: 48 days

Countries

India

Contacts

Public ContactDr K Saravanasingh

National Institute of Siddha

k.saravanasingh@gmail.com8939336951

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026